Alise S. Reicin's most recent trade in Tectonic Therapeutic Inc. was a trade of 924 Common Stock done at an average price of $30.3 . Disclosure was reported to the exchange on June 20, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tectonic Therapeutic Inc | Alise S. Reicin | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.34 per share. | 20 Jun 2026 | 924 | 310,623 | - | 30.3 | 28,034 | Common Stock |
| Immatics N.V | Alise S. Reicin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2026 | 48,000 | 48,000 | - | - | Stock Option (Right to Buy) | |
| Sana biotech Inc | Alise S. Reicin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2026 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Alise S. Reicin | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 21.10 per share. | 11 Feb 2026 | 2,500 | 237,547 | - | 21.1 | 52,750 | Common Stock |
| Tectonic Therapeutic Inc | Alise S. Reicin | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.22 per share. | 04 Feb 2026 | 4,104 | 235,047 | - | 23.2 | 95,295 | Common Stock |
| Tectonic Therapeutic Inc | Alise S. Reicin | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.38 per share. | 31 Dec 2025 | 10,966 | 239,151 | - | 2.4 | 26,099 | Common Stock |
| Tectonic Therapeutic Inc | Alise S. Reicin | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2025 | 10,966 | 22,957 | - | - | Employee Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Alise S. Reicin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Sep 2025 | 26,710 | 26,710 | - | - | Employee Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Alise S. Reicin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Sep 2025 | 14,700 | 228,185 | - | 0 | Common Stock | |
| Tectonic Therapeutic Inc | Alise S. Reicin | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.81 per share. | 20 Jun 2025 | 859 | 213,485 | - | 19.8 | 17,017 | Common Stock |
| Sana biotech Inc | Alise S. Reicin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Alise S. Reicin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 101,953 | 101,953 | - | - | Employee Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Alise S. Reicin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 36,047 | 214,344 | - | 0 | Common Stock | |
| Tectonic Therapeutic Inc | Alise S. Reicin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2024 | 11,717 | 178,297 | - | 0 | Common Stock | |
| Tectonic Therapeutic Inc | Alise S. Reicin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2024 | 6,000 | 6,000 | - | - | Employee Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Alise S. Reicin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 289,600 | 289,600 | - | - | Employee Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Alise S. Reicin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 166,580 | 166,580 | - | - | Common Stock | |
| Tectonic Therapeutic Inc | Alise S. Reicin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 124,530 | 124,530 | - | - | Common Stock | |
| Tectonic Therapeutic Inc | Alise S. Reicin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 33,923 | 33,923 | - | - | Employee Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Alise S. Reicin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 23,380 | 23,380 | - | - | Employee Stock Option (Right to Buy) | |
| Sana biotech Inc | Alise S. Reicin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Sana biotech Inc | Alise S. Reicin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 54,278 | 54,278 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc | Alise S. Reicin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 23,000 | 23,000 | - | - | Option (Right to Buy) | |
| Sana biotech Inc | Alise S. Reicin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc | Alise S. Reicin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 18,000 | 18,000 | - | - | Option (Right to Buy) | |
| Sana biotech Inc | Alise S. Reicin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) |